Cargando…

Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI

OBJECTIVES: To investigate whether glioma isocitrate dehydrogenase (IDH) 1 mutation and vascular endothelial growth factor (VEGF) expression can be estimated by histogram analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). METHODS: Chinese Glioma Genome Atlas (CGGA) database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yue, Chen, Yue, Wang, Jie, Kang, Jin Juan, Shen, Dan Dan, Jia, Zhong Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793903/ https://www.ncbi.nlm.nih.gov/pubmed/33425744 http://dx.doi.org/10.3389/fonc.2020.593102

Ejemplares similares

The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China
por: Shen, Guiquan, et al.
Publicado: (2020)

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics
por: Du, Ningfang, et al.
Publicado: (2022)

Combination of the Distance From Tumor Edge to Subventricular Zone and IDH Mutation Predicts Prognosis of Patients With Glioma
por: Zhang, Shuixian, et al.
Publicado: (2021)

Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas
por: Dijkstra, Hildebrand, et al.
Publicado: (2019)

Convolutional neural network to predict IDH mutation status in glioma from chemical exchange saturation transfer imaging at 7 Tesla
por: Yuan, Yifan, et al.
Publicado: (2023)

Promoter Methylation Analysis of IDH Genes in Human Gliomas
por: Flanagan, Simon, et al.
Publicado: (2012)

A Quantitative Assessment of Pre-Operative MRI Reports in Glioma Patients: Report Metrics and IDH Prediction Ability
por: Cao, Hang, et al.
Publicado: (2021)

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
por: Haider, Ali S., et al.
Publicado: (2023)

Peritumoral Enhancement for the Evaluation of Myometrial Invasion in Low-Risk Endometrial Carcinoma on Dynamic Contrast-Enhanced MRI
por: Cui, Tingting, et al.
Publicado: (2022)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study
por: Zhang, Jun, et al.
Publicado: (2021)

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience
por: Cho, Uiju, et al.
Publicado: (2021)

Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer
por: Li, Zhiheng, et al.
Publicado: (2022)

A Nomogram Modeling (11)C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
por: Zhou, Weiyan, et al.
Publicado: (2020)

Integrated Analysis of the Clinical and Molecular Characteristics of IDH Wild-Type Gliomas in the Chinese Glioma Genome Atlas
por: Wang, Peng, et al.
Publicado: (2021)

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Histogram Analysis of Diffusion Weighted Imaging in Low-Grade Gliomas: in vivo Characterization of Tumor Architecture and Corresponding Neuropathology
por: Gihr, Georg Alexander, et al.
Publicado: (2020)

Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI
por: Chen, Yanqiong, et al.
Publicado: (2018)

IDH1 mutation detection by droplet digital PCR in glioma
por: Wang, Jing, et al.
Publicado: (2015)

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours
por: Molenaar, Remco J, et al.
Publicado: (2017)

Swin Transformer Improves the IDH Mutation Status Prediction of Gliomas Free of MRI-Based Tumor Segmentation
por: Wu, Jiangfen, et al.
Publicado: (2022)

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019)

Frequency and Prognostic Value of IDH Mutations in Korean Patients With Cholangiocarcinoma
por: Kim, Nah Ihm, et al.
Publicado: (2020)

Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma
por: Li, Chao, et al.
Publicado: (2019)

Prediction of Lower Grade Insular Glioma Molecular Pathology Using Diffusion Tensor Imaging Metric-Based Histogram Parameters
por: Huang, Zhenxing, et al.
Publicado: (2021)

CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas
por: Fu, Weilun, et al.
Publicado: (2021)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Li, Zongfang, et al.
Publicado: (2020)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation
por: Liu, Aizhen, et al.
Publicado: (2016)

Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
por: Guo, Jinxiu, et al.
Publicado: (2021)

Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
por: Park, Chul-Kee, et al.
Publicado: (2015)

IDH1 Mutation in Gliomas in Mosul City - Iraq
por: Saeed, Mohammed Sami
Publicado: (2015)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
por: Murugan, A. K., et al.
Publicado: (2022)

RAB42 Promotes Glioma Pathogenesis via the VEGF Signaling Pathway
por: Liu, Baoling, et al.
Publicado: (2021)

Machine Learning Decision Tree Models for Differentiation of Posterior Fossa Tumors Using Diffusion Histogram Analysis and Structural MRI Findings
por: Payabvash, Seyedmehdi, et al.
Publicado: (2020)

Histogram analysis of multi-model high-resolution diffusion-weighted MRI in breast cancer: correlations with molecular prognostic factors and subtypes
por: Qin, Yanjin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b2d20uh2m7kri1peagrf83u76h